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Abstract: Objective: In a cross sectional study, 75 patients (42 males and 33 females) on continuous ambu-
latory peritoneal dialysis (CAPD) were enrolled from October 2007 to February 2008. Serum levels of leptin, 
albumin, triglyceride, dialysis adequacy (total KT/V), renal creatinine clearance (Cr Cl), mid arm circumference 
and demographic fi ndings were measured in all patients. 
Results: The mean age of patients was 53±14.76. The history of hemodialysis was seen in 23 patients. Mean 
serum leptin level in women and men were 27±23μg/l and 16±13μg/l, respectively. A signifi cant correlation of 
serum leptin level with body mass index (BMI) (p<0.001) and renal Cr Cl (p<0.001) was found. There was no 
signifi cant correlation of serum leptin level with KT/V, duration of renal failure, serum triglycerides (TG), serum 
low density lipoprotein (LDL) cholesterol and mid arm circumference (p>0.05). 
Conclusions: To our knowledge, this is probably the fi rst study to report that serum leptin level has a direct posi-
tive correlation with renal Cr Cl in CAPD patients. This may explain the increase in mortality in patients with 
lower serum leptin levels (Tab. 2, Fig. 2, Ref. 25). Full Text in PDF www.elis.sk.
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Leptin is a 16000-Dalton protein that is produced by fat cells; 
it is secreted into the blood stream, attaches to the leptin binding 
protein, and reaches the hypothalamus via cerebral spinal fl uid 
(CSF). It decreases the neuropeptid Y, suppresses appetite, and 
by blocking MSH it decreases hunger which in turn decreases 
the weight (1). Kidneys play an important role in metabolism and 
excretion of leptin. Leptin is freely fi ltered into glomerulus but 
with very little excretion in urine (2). This is probably because it 
is reabsorbed and destructed in tubules (3). Serum leptin level is 
higher in chronic renal failure, hemodialysis and CAPD patients 
compared to general population (4, 5). Some studies reported that 
the level of leptin in CAPD patients and women is higher compared 
to hemodialysis patients and men, respectively (6, 7) but in other 
study, serum leptin level has been higher in hemodialysis versus 
CAPD patients (8). The exact cause of elevated serum leptin level 
in patients suffering from renal failure is not clear; however some 
factors including hemodialysis membrane and type of dialysis 
(hemodialysis versus peritoneal dialysis) (9), low serum eryth-
ropoietin level (10), chronic infl ammation and hyperinsulinemia 
(11) may also play a role. Hyperleptinemia has probably a role in 
anorexia and malnutrition of dialysis patients, but there is a con-
troversy in this regard (12–15). To our knowledge there are only 
a few comprehensive studies on the relation of serum leptin level 
with nutritional factors. Thus we conducted the present study to 
fi nd this relation.
Methods and materials
Patients who had been at least for three months on CAPD pro-
gram in Al-Zahra university hospital in Isfahan were enrolled in 
this cross-sectional study after their written and informed consent 
had been taken. Information was collected from the questionnaire 
by PD nurse and from patient fi les covering the period from Oc-
tober 2007 to February 2008. The inclusion criterion was perito-
neal dialysis for at least 3 months, and exclusion criteria included 
patient incompliance, inadequate blood sampling and peritonitis 
during the study.
The sample volume was calculated by formula:
 
n = [(z1 + z2)2 (1 - r2) / r2] + 2,
where n was calculated to equal 63 patients. Of 101 CAPD patients, 
75 patients fulfi lled the inclusion criteria and entered the study. 
For sampling, the method of simple random sampling was used. 
The patients fi lled in a questionnaire, went through physical and 
laboratory examinations, and their patient fi les were examined. 
Demographic information of patients was obtained from their 
fi les. Fasting blood sample was taken at the peritoneal dialysis 
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(PD) clinic for measurement of serum leptin (DRG kit, RIA, Ger-
many), cholesterol, triglyceride, LDL, and HDL. Serum, dialysate 
and urine were analysed for creatinine, serum urea concentration, 
and albumin (bromo Cresol Green {BCG} method). Body mass 
index (BMI) was calculated by formula (BMI = weight {kg}/
height2 {meter}), and mid arm circumference was measured by 
fabric meter. All data collected by PD nurse and data related to 
calculating the total KT/V and renal Cr Cl were analyzed by PD 
Adequest 2 software, Baxter ,USA. 
All laboratory tests were taken after 10 hours of fasting and 
checked in a single laboratory. Separated plasma of patients was 
kept in –20c environment. After collecting all samples, the vari-
ables were measured. T-test and univariate general linear models 
(GLM) were used to analyze the variables statistically. All data and 
information are confi dential, and for blood sampling an informed 
consent was taken from every patient.
Results
In a cross-sectional study carried out in a single center from 
October 2007 to February 2008, 75 CAPD patients (42 males and 
33 females) fi nished the study.
The mean age of patients was 53±14.76 years, (in range of 
20–81 years). The most common cause of end-stage renal disease 
was diabetes mellitus (48 %) (Tab. 1). The mean age of DM pa-
tients was higher than that of patients without DM (60 years vs 
46 years, respectively, p=0.028). 
Twenty three (30 %) patients had the history of hemodialy-
sis. In 58 (77 %) patients, renal Cr Cl was less than 6 ml/min and 
in 17 (23 %) patients it was equal or greater than 6ml/min. The 
mean serum leptin level in women and men were 33±4.44 μg/l and 
24±3.4 μg/l, respectively (p=0.001). By using univariate general 
linear model, a negative relationship has been shown between age 
and serum leptin level (p=0.028). There was a positive relation 
between the serum leptin level and the duration of chronic kidney 
disease (p=0.01). This means that patients with a more prolonged 
renal failure had higher serum leptin levels. Mean BMI had a ris-
ing pattern up to 70 years and began to decline thereafter (Tab. 2). 
Figure 1 shows that serum leptin level had a positive cor-
relation with renal Cr Cl (p=0.007). There was no correlation of 
serum leptin level with mid arm circumference, serum TG, and 
total and LDL cholesterol levels (p>0.05). There was a negative 
relationship between the serum leptin level and the duration of 
hemodialysis (p=0.043), but there was no relation with the dura-
tion of peritoneal dialysis, albumin and total KT/V (p>0.05).There 
Cause Frequency Percent
Polycystic disease 1 1.3
DM + HTN 4 5.3
DM 32 42.7
Glomerulonephritis 1 1.3
Gout 1 1.3
hypertension 17 22.7
pregnancy 2 2.7
Renal stone 4 5.3
SLE 2 2.7
Unknown 11 14.6
Total 75 100
Tab. 1. Causes of ESRD in patients.
Number Minimum Maximum Mean Std. Deviation
Leptin (μg/lit) 75 0.09 101.00 22.00 23.00
Mid arm circumference(cm) 75 18.50 38.00 27.21 4.38
BMI (kg/m2) 75 14.20 33.30 24.26 3.89
TG (mg/dl) 75 52.00 513.00 156.15 78.77
LDL Cholesterol (mg/dl) 75 36.00 216.00 104.77 35.32
HDL Cholesterol (mg/dl) 75 28.00 59.00 44.10 6.88
Total Cholesterol (mg/dl) 75 109.00 283.00 179.12 39.72
KT/V 75 1.08 4.80 2.42 0.80
Cr Cl (ml/min) 75 .0000 29.95 3.71 4.86
WEIGHT (kg) 75 36.00 95.00 66.83 13.49
Duration of renal failure (months) 75 0.50 300.00 43.47 56.03
Duration of peritoneal dialysis (months) 75 3.00 70.00 20.16 13.79
HTN 75 0.00 1.00 0.77 0.42
Duration of hemodialysis (months) 75 0.00 72.00 4.27 12.61
Number of PD exchanges per day 75 0.36 5.00 3.76 0.88
Tab. 2. Clinical and biochemical parameters of patients during the study.
Fig. 1. Relationship between serum leptin and Cr Cl of patients 
(p=0.007).
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was a signifi cant correlation between the serum leptin level and 
BMI (p<0.001) (Fig. 2). 
Discussion
Some studies showed that serum leptin level is higher in fe-
male than in male population, as well as that it is higher in CAPD 
patients compared with those subdued to hemodialysis. Higher 
level of serum leptin level in CAPD patients compared to HD 
patients may be due to higher fat mass and serum insulin level in 
CAPD patients (6, 16–18). 
Serum leptin level may have direct correlation with body fat 
mass, serum triglyceride, serum total and LDL cholesterol (13, 
14, 16). Stenvinkel et al (19) reported higher serum leptin level 
in CAPD patients with weight loss but not in patients with weight 
gain. So leptin can be used as a malnutrition index in CAPD pa-
tients, although in some studies, leptin has been presented as an 
index of good nutritional status (14) and low serum leptin level 
as a possible predictor of higher mortality in patients with chronic 
kidney disease (20). 
Our results showed that serum leptin level is higher in women 
compared to men and serum leptin level had a linear correlation 
with BMI, which is similar to the fi ndings of Parry (16), Vignioble 
(21) and Kagen (22) but different from those of Kim (23). 
These differences could be due to discrepancies in numbers of 
patients in these studies. In present study, serum leptin level was 
higher in patients with renal Cr CL ≥6 ml/min wich may explain the 
higher mortality in CAPD patients with lower serum leptin level. 
Yilmaz et al (13) reported that in CAPD patients, serum leptin 
levels correlate with age and body mass index (BMI), however in 
Kastrainion (12) and Taskapan (24) studies they correlated with 
serum triglyceride and cholesterol. While in Stenvinked (19) study 
on 36 CAPD patients, serum leptin level had an adverse correla-
tion with BMI, there was no correlation of serum leptin level with 
serum albumin, terasferin and cholesterol in Aguilera (15) study 
in patients with BMI >25 kg/m2. In our study, there was no cor-
relation of serum leptin level with mid arm circumference, serum 
triglyceride, total and LDL cholesterol, and duration of peritoneal 
dialysis (PD). In Vignioble (21) study, serum leptin level had also 
no correlation with the duration of PD. The controversy of results 
between different studies may be due to different sample size, sex 
distribution, and methods of patients’ evaluation. In our study, se-
rum leptin level had no correlation with total KT/V which is con-
sistent with the results of Parry RG (16) and Rodríguez-Carmona 
(25) results. Therefore we cannot use serum leptin as an index of 
peritoneal dialysis adequacy.
In conclusion, this is probably the fi rst report of a positive cor-
relation of serum leptin level with renal Cr Cl in CAPD patients. 
This may explain the increase in mortality in patients with lower 
serum leptin level. 
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